Table 2.

Associations of AGEs with patient characteristics.

	PEN (pmol/mgCre, log)		CML (µg/mL, log)
	Correlation coefficient	P value	Correlation coefficient	P value
Age, years	0.230	< 0.001	0.212	< 0.001
Body height, cm	− 0.138	< 0.01	− 0.145	< 0.01
Body weight, kg	0.053	0.27	− 0.041	0.39
Trunk circumference, cm	0.156	< 0.01	0.077	0.11
Trunk fat, %	0.031	0.52	0.059	0.22
Hip fat, %	0.024	0.61	0.117	< 0.05
Lumbar BMD, g/cm2	0.048	0.32	− 0.180	< 0.001
Hip BMD, g/cm2	− 0.017	0.72	− 0.072	0.13
Albumin, g/dL	0.016	0.74	− 0.100	< 0.05
BUN, mg/dL	0.064	0.19	0.131	< 0.01
Creatinine, mg/dL	0.078	0.099	0.030	0.54
Uric acid, mg/dL	0.134	< 0.01	0.018	0.71
eGFR, mL/min/1.73m2	− 0.097	< 0.05	− 0.080	0.094
Total cholesterol, mg/dL	− 0.061	0.20	0.064	0.18
Triglycerides, mg/dL	0.014	0.78	0.044	0.36
HbA1c, %	0.146	< 0.01	0.171	< 0.001
Homocysteine, nmol/mL, log	0.160	< 0.001	0.019	0.69
NTx, nmolBCE/mmolCre, log	0.145	< 0.01	− 0.014	0.77
Osteocalcin, ng/mL, log	− 0.044	0.38	0.048	0.34
Sclerostin, pmol/L, log	0.079	0.12	0.132	< 0.01
FGF23, pg/mL, log	0.062	0.22	0.105	< 0.05
Leptin, ng/mL, log	0.015	0.77	0.046	0.36
Adiponectin, µg/mL, log	0.063	0.21	0.045	0.38

AGEs advanced glycation end products, PEN pentosidine, CML carboxymethyl-lysine, BMD bone mineral density, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A_1c, NTx cross-linked N-telopeptide of type I collagen, FGF23 fibroblast growth factor 23.